Malley Thomas bought KNSA
May 29, 2026 · Form 4 insider transaction
Malley Thomas bought 2,026 shares of Kiniksa Pharmaceuticals International, plc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,026
Price
$0.00
Total value
N/A
InsiderMalley Thomas
RoleDirector
SecurityRestricted Share Units
Transaction codeA: Grant or award
Transaction dateMay 29, 2026
Filing dateJune 2, 2026
Shares owned after2,026
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.; The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026.